Pancreatic adenocarcinoma and pancreatic high-grade neuroendocrine carcinoma: two sides of the moon

Capasso M, Franceschi M, Rodriguez-Castro KI, Crafa P, Cambiè G, Miraglia C, et al. Epidemiology and risk factors of pancreatic cancer. Acta BioMed. 2018;89:141–6.

PubMed  Google Scholar 

Martens S, Lefesvre P, Nicolle R, Biankin AV, Puleo F, Van Laethem JL, et al. Different shades of pancreatic ductal adenocarcinoma, different paths towards precision therapeutic applications. Ann Oncol. 2019;30(9):1428–36.

CAS  PubMed  Article  Google Scholar 

Schlitter AM, Segler A, Steiger K, Michalski CW, Jäger C, Konukiewitz B, et al. Molecular, morphological and survival analysis of 177 resected pancreatic ductal adenocarcinomas (PDACs): identification of prognostic subtypes. Sci Rep. 2017;1(7):41064.

Article  CAS  Google Scholar 

Lawrence B, Gustafsson BI, Chan A, Svejda B, Kidd M, Modlin IM. The epidemiology of gastroenteropancreatic neuroendocrine tumors. Endocrinol Metab Clin North Am. 2011;40(1):1–18.

PubMed  Article  Google Scholar 

Rindi G, Wiedenmann B. Neuroendocrine neoplasms of the gut and pancreas: new insights. Nat Rev Endocrinol. 2011;8(1):54–64.

PubMed  Article  CAS  Google Scholar 

Păun I, Becheanu G, Costin AI, Constantin VD, Mihai GM, Radu L, et al. Aspects regarding nomenclature, classification and pathology of neuroendocrine neoplasms of the digestive system: a review. Rom J Morphol Embryol. 2018;59(3):673–8.

PubMed  Google Scholar 

Watanabe I, Sasaki S, Konishi M, Nakagohri T, Inoue K, Oda T, et al. Onset symptoms and tumor locations as prognostic factors of pancreatic cancer. Pancreas. 2004;28(2):160–5.

PubMed  Article  Google Scholar 

Mills K, Birt L, Emery JD, Hall N, Banks J, Johnson M, et al. Understanding symptom appraisal and help-seeking in people with symptoms suggestive of pancreatic cancer: a qualitative study. BMJ Open. 2017;7(9): e015682.

PubMed  PubMed Central  Article  Google Scholar 

McGuigan A, Kelly P, Turkington RC, Jones C, Coleman HG, McCain RS. Pancreatic cancer: a review of clinical diagnosis, epidemiology, treatment and outcomes. World J Gastroenterol. 2018;24(43):4846–61.

PubMed  PubMed Central  Article  Google Scholar 

Garcia-Carbonero R, Sorbye H, Baudin E, Raymond E, Wiedenmann B, Niederle B, et al. ENETS consensus guidelines for high-grade gastroenteropancreatic neuroendocrine tumors and neuroendocrine carcinomas. Neuroendocrinology. 2016;103(2):186–94.

CAS  PubMed  Article  Google Scholar 

Yao W-Q, Wu X, Li G-D, Wu W-L, Wang W-Y. ACTH-secreting pancreatic neuroendocrine carcinoma with ovarian and pelvic metastases causing cushing’s syndrome: a case report. Int J Clin Exp Pathol. 2015;8(11):15396–401.

PubMed  PubMed Central  Google Scholar 

Pescatori LC, Festa S, Panzuto F, Pilozzi E, Prosperi D, Rinzivillo M, et al. A case of pancreatic small cell neuroendocrine carcinoma associated with SIADH. Pancreas. 2016;45(5):e20-22.

PubMed  Article  Google Scholar 

Ren B, Liu X, Suriawinata AA. Pancreatic ductal adenocarcinoma and its precursor lesions: histopathology, cytopathology, and molecular pathology. Am J Pathol. 2019;189(1):9–21.

PubMed  Article  Google Scholar 

Nagtegaal ID, Odze RD, Klimstra D, Paradis V, Rugge M, Schirmacher P, et al. The 2019 WHO classification of tumours of the digestive system. Histopathology. 2020;76(2):182–8.

PubMed  Article  Google Scholar 

Patlas M, Deitel W, Taylor B, Gallinger S, Wilson SR. Focal chronic pancreatitis mimicking pancreatic head carcinoma: are there suggestive features on ultrasound? Can Assoc Radiol J. 2007;58(1):15–21.

PubMed  Google Scholar 

Zhang S, Defrias DVS, Alasadi R, Nayar R. Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA): experience of an academic centre in the USA. Cytopathology. 2010;21(1):35–43.

CAS  PubMed  Article  Google Scholar 

Lee ES, Lee JM. Imaging diagnosis of pancreatic cancer: a state-of-the-art review. World J Gastroenterol. 2014;20(24):7864–77.

PubMed  PubMed Central  Article  Google Scholar 

Wartski M, Sauvanet A. 18F-FDG PET/CT in pancreatic adenocarcinoma: a role at initial imaging staging? Diagn Interv Imaging. 2019;100(12):735–41.

CAS  PubMed  Article  Google Scholar 

Wang Z, Chen J-Q, Liu J-L, Qin X-G, Huang Y. FDG-PET in diagnosis, staging and prognosis of pancreatic carcinoma: a meta-analysis. World J Gastroenterol. 2013;19(29):4808–17.

PubMed  PubMed Central  Article  Google Scholar 

Duffy MJ, Sturgeon C, Lamerz R, Haglund C, Holubec VL, Klapdor R, et al. Tumor markers in pancreatic cancer: a European group on tumor markers (EGTM) status report. Ann Oncol. 2010;21(3):441–7.

CAS  PubMed  Article  Google Scholar 

Goonetilleke KS, Siriwardena AK. Systematic review of carbohydrate antigen (CA 19–9) as a biochemical marker in the diagnosis of pancreatic cancer. Eur J Surg Oncol. 2007;33(3):266–70.

CAS  PubMed  Article  Google Scholar 

Humphris JL, Chang DK, Johns AL, Scarlett CJ, Pajic M, Jones MD, et al. The prognostic and predictive value of serum CA19.9 in pancreatic cancer. Ann Oncol. 2012;23(7):1713–22.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Lee DW, Kim MK, Kim HG. Diagnosis of pancreatic neuroendocrine tumors. Clin Endosc. 2017;50(6):537–45.

PubMed  PubMed Central  Article  Google Scholar 

Kim JH, Eun HW, Kim YJ, Lee JM, Han JK, Choi B-I. Pancreatic neuroendocrine tumour (PNET): staging accuracy of MDCT and its diagnostic performance for the differentiation of PNET with uncommon CT findings from pancreatic adenocarcinoma. Eur Radiol. 2016;26(5):1338–47.

PubMed  Article  Google Scholar 

Lee L, Ito T, Jensen RT. Imaging of pancreatic neuroendocrine tumors: recent advances, current status, and controversies. Expert Rev Anticancer Ther. 2018;18(9):837–60.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Li J, Lin JP, Shi LH, Wang WJ, Li AQ, Si JM, et al. How reliable is the Ki-67 cytological index in grading pancreatic neuroendocrine tumors? a meta-analysis. J Dig Dis. 2016;17(2):95–103.

CAS  PubMed  Article  Google Scholar 

Jeon SK, Lee JM, Joo I, Lee ES, Park HJ, Jang J-Y, et al. Nonhypervascular pancreatic neuroendocrine tumors: differential diagnosis from pancreatic ductal adenocarcinomas at MR imaging-retrospective cross-sectional study. Radiology. 2017;284(1):77–87.

PubMed  Article  Google Scholar 

Binderup T, Knigge U, Loft A, Federspiel B, Kjaer A. 18F-fluorodeoxyglucose positron emission tomography predicts survival of patients with neuroendocrine tumors. Clin Cancer Res. 2010;16(3):978–85.

CAS  PubMed  Article  Google Scholar 

Korse CM, Taal BG, Vincent A, van Velthuysen M-LF, Baas P, Buning-Kager JCGM, et al. Choice of tumour markers in patients with neuroendocrine tumours is dependent on the histological grade A. marker study of chromogranin A, neuron specific enolase, progastrin-releasing peptide and cytokeratin fragments. Eur J Cancer. 2012;48(5):662–71.

CAS  PubMed  Article  Google Scholar 

Strosberg JR, Halfdanarson TR, Bellizzi AM, Chan JA, Dillon JS, Heaney AP, et al. The north American neuroendocrine tumor society consensus guidelines for surveillance and medical management of midgut neuroendocrine tumors. Pancreas. 2017;46(6):707–14.

PubMed  PubMed Central  Article  Google Scholar 

Jain R, Fischer S, Serra S, Chetty R. The use of cytokeratin 19 (CK19) immunohistochemistry in lesions of the pancreas, gastrointestinal tract, and liver. Appl Immunohistochem Mol Morphol. 2010;18(1):9–15.

CAS  PubMed  Article  Google Scholar 

Vilá MR, Balagué C, Real FX. Cytokeratins and mucins as molecular markers of cell differentiation and neoplastic transformation in the exocrine pancreas. Zentralbl Pathol. 1994;140(3):225–35.

PubMed  Google Scholar 

Wang S, You L, Dai M, Zhao Y. Mucins in pancreatic cancer: a well-established but promising family for diagnosis, prognosis and therapy. J Cell Mol Med. 2020;24(18):10279–89.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Nagata K, Horinouchi M, Saitou M, Higashi M, Nomoto M, Goto M, et al. Mucin expression profile in pancreatic cancer and the precursor lesions. J Hepatobiliary Pancreat Surg. 2007;14(3):243–54.

PubMed  Article  Google Scholar 

Brosens LAA, Hackeng WM, Offerhaus GJ, Hruban RH, Wood LD. Pancreatic adenocarcinoma pathology: changing ‘landscape.’ J Gastrointest Oncol. 2015;6(4):358–74.

PubMed  PubMed Central  Google Scholar 

Waddell N, Pajic M, Patch A-M, Chang DK, Kassahn KS, Bailey P, et al. Whole genomes redefine the mutational landscape of pancreatic cancer. Nature. 2015;518(7540):495–501.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Sausen M, Phallen J, Adleff V, Jones S, Leary RJ, Barrett MT, et al. Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients. Nat Commun. 2015;7(6):7686.

Article  Google Scholar 

Vincent A, Herman J, Schulick R, Hruban RH, Goggins M. Pancreatic cancer. Lancet Lond Engl. 2011;378(9791):607–20.

Article  Google Scholar 

Xu Z, Pothula SP, Wilson JS, Apte MV. Pancreatic cancer and its stroma: a conspiracy theory. World J Gastroenterol. 2014;20(32):11216–29.

PubMed  PubMed Central  Article  Google Scholar 

Moffitt RA, Marayati R, Flate EL, Volmar KE, Loeza SGH, Hoadley KA, et al. Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma. Nat Genet. 2015;47(10):1168–78.

CAS  PubMed 

留言 (0)

沒有登入
gif